Bio-Connect
293T(Human) Cell Lysate at 30 ug probed with Integrin alpha 2/CD49b Polyclonal Antibody (bs-10132R) at 1:300 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
293T(Human) Cell Lysate at 30 ug probed with Integrin alpha 2/CD49b Polyclonal Antibody (bs-10132R) at 1:300 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
293T(Human) Cell Lysate at 30 ug probed with Integrin alpha 2/CD49b Polyclonal Antibody (bs-10132R) at 1:300 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.

Integrin alpha 2 Polyclonal Antibody

BS-10132R
Bioss
ApplicationsWestern Blot, ELISA
Product group Antibodies
TargetITGA2
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bioss
  • Product Name
    Integrin alpha 2/CD49b Polyclonal Antibody
  • Delivery Days Customer
    16
  • Applications
    Western Blot, ELISA
  • Applications Supplier
    WB(1:300-5000), ELISA(1:500-1000)
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 ug/ul
  • Conjugate
    Unconjugated
  • Gene ID3673
  • Target name
    ITGA2
  • Target description
    integrin subunit alpha 2
  • Target synonyms
    BR, CD49B, FMAIT3, GPIa, HPA-5, VLA-2, VLAA2, integrin alpha-2, CD49 antigen-like family member B, alpha 2 integrin, alpha 2 subunit of VLA-2 receptor, collagen receptor, glycoprotein Ia, human platelet alloantigen 5, human platelet alloantigen system 5, integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor), platelet antigen Br, platelet glycoprotein GPIa, platelet membrane glycoprotein Ia, very late activation protein 2 receptor, alpha-2 subunit, very late activation receptor alpha-2 subunit, very late activation receptor subunit alpha-2
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP17301
  • Protein Name
    Integrin alpha-2
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • Application of luteolin nanomicelles anti-glioma effect with improvement in vitro and in vivo. Zheng S et al., 2017 Sep 22, Oncotarget
    Read more